 In May 2014, Kite Pharma filed a registration with the SEC for an initial public offering (IPO) of its common stock.In June 2014, Kite Pharma sold 8,625,000 shares of its common stock in their IPO at $17.00 per share, for gross proceeds of $146.6 million.The company listed on the NASDAQ Global market under the symbol “KITE.”

In December 2014, Kite Pharma sold 4,007,750 shares of it common stock in their follow-on offering at $54.00 per share, for gross proceeds of $216.4 million.